| 04/08/26 | 16:09:25 | 4 Aug 2026 | | Director/PDMR Shareholding - ESPP |
| 28/07/26 | 09:15:21 | 28 Jul 2026 | | Holding(s) in Company |
| 27/07/26 | 07:00:06 | 27 Jul 2026 | | Trading Statement |
| 24/07/26 | 07:00:05 | 24 Jul 2026 | | AOTI achieves transformational milestone |
| 19/06/26 | 07:00:04 | 19 Jun 2026 | | Director/PDMR Shareholding – Share purchase |
| 21/05/26 | 11:15:36 | 21 May 2026 | | Result of AGM |
| 01/05/26 | 07:00:06 | 1 May 2026 | | Employee Share Purchase Plan |
| 27/04/26 | 07:00:10 | 27 Apr 2026 | | Real-world study of AOTI’s TWO2® therapy |
| 23/04/26 | 07:00:06 | 23 Apr 2026 | | Grant of awards under Long Term Incentive Plan |
| 21/04/26 | 07:00:07 | 21 Apr 2026 | | 2025 Annual Report and Notice of AGM |
| 02/04/26 | 17:17:56 | 2 Apr 2026 | | Director/PDMR Shareholding |
| 30/03/26 | 07:00:11 | 30 Mar 2026 | | Final Results |
| 23/02/26 | 07:00:12 | 23 Feb 2026 | | Full Year Trading Update and Notice of Results |
| 15/12/25 | 10:17:34 | 15 Dec 2025 | | Holding(s) in Company |
| 06/10/25 | 07:00:09 | 6 Oct 2025 | | Appointment of Joint Corporate Broker |
| 22/09/25 | 07:00:12 | 22 Sept 2025 | | 2025 Interim Results |
| 08/09/25 | 07:00:11 | 8 Sept 2025 | | Notice of Results |
| 03/09/25 | 07:00:12 | 3 Sept 2025 | | NICE fast track recommendation for Topical Oxygen |
| 04/08/25 | 07:00:14 | 4 Aug 2025 | | Director/PDMR Shareholding |
| 01/08/25 | 10:03:21 | 1 Aug 2025 | | Holding(s) in Company |
| 31/07/25 | 11:02:24 | 31 Jul 2025 | | Director/PDMR Shareholding |
| 31/07/25 | 07:00:13 | 31 Jul 2025 | | Results of Placing |
| 30/07/25 | 16:36:01 | 30 Jul 2025 | | Proposed Placing in AOTI Inc. |
| 21/07/25 | 07:00:10 | 21 Jul 2025 | | California Medicaid Provider ID Awarded |
| 21/07/25 | 07:00:08 | 21 Jul 2025 | | Half Year Trading and FY 2025 Guidance Update |
| 25/06/25 | 13:24:06 | 25 Jun 2025 | | Result of AGM |
| 23/06/25 | 07:00:10 | 23 Jun 2025 | | AOTI unlocks broad market access in Germany |
| 18/06/25 | 07:00:08 | 18 Jun 2025 | | End of Distribution Compliance Period |
| 27/05/25 | 07:00:07 | 27 May 2025 | | 2024 Annual Report and Notice of AGM |
| 19/05/25 | 07:00:09 | 19 May 2025 | | Presentation at AJ Bell and Shares Spotlight Event |
| 13/05/25 | 07:00:09 | 13 May 2025 | | Director Shareholding - Share Purchase |
| 07/05/25 | 07:00:11 | 7 May 2025 | | Director Shareholding - Share Purchase |
| 02/05/25 | 11:14:52 | 2 May 2025 | | Director/PDMR Shareholding |
| 28/04/25 | 07:00:08 | 28 Apr 2025 | | 2024 Final Results |
| 23/04/25 | 07:00:09 | 23 Apr 2025 | | Investor Presentation via Investor Meet Company |
| 22/04/25 | 07:00:14 | 22 Apr 2025 | | TWO2® in NHS supply chain framework agreement |
| 09/04/25 | 10:06:21 | 9 Apr 2025 | | Notification of Major Holdings |
| 25/03/25 | 17:59:57 | 25 Mar 2025 | | Director/PDMR Shareholding |
| 12/02/25 | 07:00:05 | 12 Feb 2025 | | Trading Update for the year ended 31 December 2024 |
| 24/01/25 | 07:00:05 | 24 Jan 2025 | | CORRECTION New Medicaid states, coverage expansion |
| 09/01/25 | 07:00:04 | 9 Jan 2025 | | New Medicaid states, payer coverage expansion |
| 17/12/24 | 12:00:00 | 17 Dec 2024 | | Grant of performance share awards under LTIP |
| 16/12/24 | 07:00:05 | 16 Dec 2024 | | Enrolment Commences for VLU Clinical Trial |
| 12/12/24 | 07:00:05 | 12 Dec 2024 | | 5 Year Veterans Administration Contract Extension |
| 20/11/24 | 12:41:35 | 20 Nov 2024 | | Holding(s) in Company |
| 11/11/24 | 07:00:09 | 11 Nov 2024 | | CMS Topical Oxygen Therapy coverage review |
| 16/09/24 | 07:00:06 | 16 Sept 2024 | | 2024 Interim Results |
| 15/08/24 | 07:00:02 | 15 Aug 2024 | | Pre-close Trading Update |
| 29/07/24 | 07:00:08 | 29 Jul 2024 | | US FDA 510(k) Clearance of NEXATM NPWT System |
| 21/06/24 | 14:45:48 | 21 Jun 2024 | | Holding(s) in Company |
